Androgen Receptor Signaling and the Emergence of Lethal Neuroendocrine Prostate Cancer With the Treatment-Induced Suppression of the Androgen Receptor: A Literature Review-Reference-Cited by-同舟云学术

Androgen Receptor Signaling and the Emergence of Lethal Neuroendocrine Prostate Cancer With the Treatment-Induced Suppression of the Androgen Receptor: A Literature Review

Published:2021-02-17 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Dhavale Meera,Abdelaal Mohamed K.,Alam A B M Nasibul,Blazin Tatjana,Mohammed Linha M,Prajapati Dhruvil,Ballestas Natalia P,Mostafa Jihan A

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference47 articles.

1. Cancer of the Prostate - Cancer Stat Facts. (2020). Accessed. August 12, 2020: https://seer.cancer.gov/statfacts/html/prost.html.

2. Genetics and biology of prostate cancer;Wang G;Genes Dev,2018

3. Cancer statistics;Siegel RL;CA Cancer J Clin,2017

4. Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology;Mohler JL;J Natl Compr Canc Netw,2019

5. Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT;Klotz L;J Clin Oncol,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Mobility Group AT-hook 2: A Biomarker Associated with Resistance to Enzalutamide in Prostate Cancer Cells;Cancers;2024-07-24

2. Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes;JAMA Oncology;2024-06-01

3. Prostate Cancer Liver Metastasis: An Ominous Metastatic Site in Need of Distinct Management Strategies;Journal of Clinical Medicine;2024-01-27

4. Zinc finger protein‑like 1 is a novel neuroendocrine biomarker for prostate cancer;International Journal of Oncology;2023-02-06

5. Genetics of neuroendocrine prostate cancer: recent progress in genetic understanding is translating into therapeutic opportunities;Current Opinion in Urology;2022-07-15